ReviewDiabetes, obesity & metabolism2014
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.
S MadsbadPubMed ↗Publisher ↗
No numbers read from the abstract.
55 papers cite it
this paperpooled ittrialcites it